Apollo Hospitals sets November 4 results as cancer drug cap tests Apollo Hospitals stock

Published on 10/15/2026 at 11:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

On August 14, 2026, Prabhudas Lilladher set INR 10,000 target. Apollo Hospitals stock posted 21.00 percent Q1 FY27 revenue growth to INR 70.44 billion.

Cancer drug policy and earnings dates

A 30.00 percent cap on cancer-drug trade margins shaped hospital stocks on October 9, 2026.
Prabhudas Lilladher set an INR 10,000 target on August 14, 2026, up from INR 9,350.
Apollo Hospitals had an INR 1.1 trillion market capitalization as of October 15, 2026.

Apollo Hospitals, INE437A01024, Illustration mit AI erstellt.

Apollo Hospitals sets November 4 results as cancer drug cap tests Apollo Hospitals stock. On October 9, 2026, hospital stocks including Apollo rose after India capped trade margins on non-scheduled anti-cancer drugs at 30.00 percent, according to The Economic Times.

Drug cap sets the immediate test

The policy could reduce prices of some cancer medicines by 70.00 percent, while Jefferies said the impact on hospital earnings should remain manageable. The brokerage also identified Apollo Hospitals among its preferred hospital operators, although the article noted that medical-consumable regulation remains a separate risk.

Three dated signals shape the stock

On August 12, 2026, Apollo Hospitals reported Q1 FY27 revenue of INR 70.44 billion, up 21.00 percent year on year, and net profit of INR 5.81 billion, up 38.40 percent, according to The Economic Times. On October 9, 2026, the 30.00 percent cancer-drug margin cap became the latest regulatory signal, and on October 12, 2026, Apollo disclosed a November 4, 2026 board meeting for financial results through September 30, 2026.

What does the target mean for earnings?

Prabhudas Lilladher raised its target to INR 10,000 from INR 9,350 on August 14, 2026, while retaining its Buy recommendation, according to DSIJ. The broker said Q1 FY27 consolidated revenue was 3.00 percent above its estimate, adjusted PAT was 5.00 percent above its estimate, and net debt declined by INR 1.20 billion sequentially to INR 7.50 billion.

November results set the next checkpoint

The Economic Times reported that Apollo Hospitals scheduled its board meeting for November 4, 2026, to consider financial results. For investors, the key comparison will be whether hospital growth continues to offset regulatory pressure on medicine and consumable margins.

Apollo Hospitals stock was trading at INR 7,869.00 on the NSE on October 15, 2026, at 2:56 p.m. IST. The finance data showed a market capitalization of INR 1.1 trillion and a 52-week range of INR 6,677.50 to INR 9,070.50.